a significant trendp = 0.016
There was a significant trend towards higher proportion of CD4 + T cells expressing TIM-3 ( p = 0.016) in Ipilimumab treated patients.
There was a significant trend towards higher proportion of CD4 + T cells expressing TIM-3 ( p = 0.016) in Ipilimumab treated patients.